Press releases
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 16, 2006Boston Scientific's second generation stent compares favorably to market leading TAXUS Express2™ stent system, even with more complex lesions
Boston Scientific Corporation (NYSE: BSX) today announced nine-month data from its TAXUS ATLAS clinical trial. The results confirmed...
-
May 16, 2006
Boston Scientific Corporation (NYSE: BSX) today announced 12-month data from its MELODIE clinical trial. The trial demonstrates the...
-
May 16, 2006Boston Scientific's second-generation stent system now approved for treatment of acute mycocardial infarction, total occlusions and in-stent restenosis
Boston Scientific Corporation (NYSE: BSX) announced today that it has received indication extensions to the European CE mark for its TAXUS®...
-
May 15, 2006
Boston Scientific Corporation (NYSE: BSX) today announced physician communications related to products in its Cardiac Rhythm Management (CRM) Group,...
-
May 11, 2006
Boston Scientific Corporation (NYSE: BSX) announced that the U.S. District Court in Delaware issued a ruling upholding two jury decisions in a...